Amyloid beta peptide (aa1-16) (N-Term) polyclonal, anti-human, mouse

Background:
This antibody is expected to recognize all reported isoforms of APP (NP_000475.1; NP_958816.1; NP_958817.1; NP_001129601.1; NP_001129602.1) and to recognize all lengths of the Amyloid beta peptide.

Other Names:
Amyloid beta A4 protein, ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, C83, P3(42), P3(40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, AICD-59, AID(59), Gamma-CTF(59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, AICD-57, AID(57), Gamma-CTF(57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50), C31, APP, A4, AD1

Antigen Types:
Synthetic Peptide

Gene Name:
APP (HGNC:620)
Gene ID:
351
Primary Accession: P05067
Other Accession: NP_000475.1; NP_958816.1; NP_958817.1; NP_001129601.1; NP_001129602.1;351;